Search research articles
Contact Us
Filters
Showing results (11-20 of 16) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 16 results.
Obstetrics and Gynecology
|
September 14, 2020
Characteristics Associated With Consent and Reasons for Declining in a Randomized Trial in Pregnancy
Gail Mallett, Kim Hill, Jessica de Voest, et al.
The Lancet. Neurology
|
June 23, 2023
Desmopressin for patients with spontaneous intracerebral haemorrhage taking antiplatelet drugs (DASH): a UK-based, phase 2, randomised, placebo-controlled, multicentre feasibility trial
Michael J R Desborough, Rustam Al-Shahi Salman, Simon J Stanworth, et al.
BMJ Open
|
June 17, 2025
Carbon footprint of a sample of clinical trials for people with neurological disorders: cross-sectional analysis
Denise Cranley, Sarah Dunn, John-Paul Taylor, et al.
BMJ Open
|
July 28, 2025
Mannitol for cerebral oedema after acute intracerebral haemorrhage (MACE-ICH): protocol for a prospective, randomised, open-label, blinded-endpoint phase IIb trial
Kailash Krishnan, Emma Grace, Lisa Woodhouse, et al.
Clinical Neurology and Neurosurgery
|
February 14, 2026
Baseline characteristics of patients recruited to the mannitol for cerebral oedema after acute intracerebral haemorrhage (MACE-ICH) trial
Kailash Krishnan, Emma Grace, Lisa Woodhouse, et al.
Theoretical Medicine and Bioethics
|
October 12, 2012
Peer review versus editorial review and their role in innovative science
Georg Steinhauser, Wolfram Adlassnig, Jesaka Ahau Risch, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 16) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 16 results.
Obstetrics and Gynecology
|
September 14, 2020
Characteristics Associated With Consent and Reasons for Declining in a Randomized Trial in Pregnancy
Gail Mallett, Kim Hill, Jessica de Voest, et al.
The Lancet. Neurology
|
June 23, 2023
Desmopressin for patients with spontaneous intracerebral haemorrhage taking antiplatelet drugs (DASH): a UK-based, phase 2, randomised, placebo-controlled, multicentre feasibility trial
Michael J R Desborough, Rustam Al-Shahi Salman, Simon J Stanworth, et al.
BMJ Open
|
June 17, 2025
Carbon footprint of a sample of clinical trials for people with neurological disorders: cross-sectional analysis
Denise Cranley, Sarah Dunn, John-Paul Taylor, et al.
BMJ Open
|
July 28, 2025
Mannitol for cerebral oedema after acute intracerebral haemorrhage (MACE-ICH): protocol for a prospective, randomised, open-label, blinded-endpoint phase IIb trial
Kailash Krishnan, Emma Grace, Lisa Woodhouse, et al.
Clinical Neurology and Neurosurgery
|
February 14, 2026
Baseline characteristics of patients recruited to the mannitol for cerebral oedema after acute intracerebral haemorrhage (MACE-ICH) trial
Kailash Krishnan, Emma Grace, Lisa Woodhouse, et al.
Theoretical Medicine and Bioethics
|
October 12, 2012
Peer review versus editorial review and their role in innovative science
Georg Steinhauser, Wolfram Adlassnig, Jesaka Ahau Risch, et al.
Page
of 2